La maladie de Parkinson en France (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Modification And NotPaula Ravenscroft

List of bibliographic references

Number of relevant bibliographic references: 4.
Ident.Authors (with country if any)Title
000519 Marie-Charlotte Lepelley [France] ; Francine Thullier [France] ; Benoît Bolmont [France] ; Francis G. Lestienne [France]Age-related differences in sensorimotor representation of space in drawing by hand
000657 Olivier Rascol [France]"Disease-modification" trials in Parkinson disease : Target populations, endpoints and study design
000712 D. Dupuy [France] ; J. P. Lesbre [France] ; P. Ger [France] ; M. Andrejak [France] ; O. Godefroy [France]Valvular heart disease in patients with Parkinson's disease treated with pergolide. Course following treatment modifications
000798 C. Warren Olanow [États-Unis] ; Robert A. Hauser [États-Unis] ; Joseph Jankovic [États-Unis] ; William Langston [États-Unis] ; Anthony Lang [Canada] ; Wemer Poewe [Autriche] ; Eduardo Tolosa [Espagne] ; Fabrizio Stocchi [Italie] ; Eldad Melamed [Israël] ; Eli Eyal [Israël] ; Olivier Rascol [France]A Randomized, Double-Blind, Placebo-Controlled, Delayed Start Study to Assess Rasagiline as a Disease Modifying Therapy in Parkinson's Disease (The ADAGIO Study) : Rationale, Design, and Baseline Characteristics

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024